TY - JOUR T1 - Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis JF - Ann Intern Med Y1 - 2007 A1 - Veldt, B.J. A1 - Heathcote, E.J. A1 - Wedemeyer, H. A1 - Reichen, J. A1 - Hofmann, W.P. A1 - Stefan Zeuzem A1 - Manns, M.P. A1 - Hansen, B.E. A1 - Schalm, S.W. A1 - H L Janssen KW - Adult KW - Antiviral Agents KW - blood KW - Canada KW - Carcinoma KW - Carcinoma,Hepatocellular KW - Cohort Studies KW - complications KW - Death KW - drug therapy KW - Drug Therapy,Combination KW - etiology KW - Europe KW - Female KW - Fibrosis KW - Follow-Up Studies KW - hepatitis KW - Hepatitis C KW - hepatitis C virus KW - Hepatitis C,Chronic KW - Humans KW - Infection KW - interferon KW - Interferon Alfa-2b KW - Interferon-alpha KW - Liver KW - Liver Cirrhosis KW - Liver Failure KW - Liver Neoplasms KW - Liver Transplantation KW - Male KW - Middle Aged KW - Mortality KW - Multicenter Studies KW - Netherlands KW - Patients KW - prevention KW - Proteins KW - Recombinant Proteins KW - Retrospective Studies KW - Ribavirin KW - Rna KW - Rna,Viral KW - Survival KW - sustained virologic response KW - therapeutic use KW - treatment KW - Treatment Outcome KW - virology VL - 147 SP - 677-684 IS - 10 ER -